Berenberg Bank Issues Pessimistic Forecast for Johnson Matthey (LON:JMAT) Stock Price

Johnson Matthey (LON:JMATGet Free Report) had its target price decreased by research analysts at Berenberg Bank from GBX 1,650 ($21.02) to GBX 1,500 ($19.11) in a research note issued on Thursday, Marketbeat.com reports. The firm presently has a “hold” rating on the stock. Berenberg Bank’s price target would suggest a potential upside of 10.38% from the stock’s previous close.

Johnson Matthey Trading Up 2.2 %

Shares of LON JMAT opened at GBX 1,359 ($17.31) on Thursday. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 63.15. The stock’s 50 day moving average price is GBX 1,510.09 and its two-hundred day moving average price is GBX 1,610.89. Johnson Matthey has a 52-week low of GBX 1,318 ($16.79) and a 52-week high of GBX 1,917.07 ($24.42). The stock has a market capitalization of £2.37 billion, a P/E ratio of 2,355.91, a PEG ratio of 49,242.50 and a beta of 0.95.

Insiders Place Their Bets

In other news, insider Stephen Oxley sold 19,554 shares of the business’s stock in a transaction on Friday, October 18th. The shares were sold at an average price of GBX 1,526 ($19.44), for a total transaction of £298,394.04 ($380,071.38). Also, insider Liam Condon purchased 27 shares of the stock in a transaction dated Wednesday, October 16th. The shares were purchased at an average price of GBX 1,505 ($19.17) per share, with a total value of £406.35 ($517.58). Insiders acquired a total of 7,479 shares of company stock valued at $10,057,890 over the last 90 days. 0.61% of the stock is owned by company insiders.

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Stories

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.